Literature DB >> 28371308

BK Virus Nephropathy: Histological Evolution by Sequential Pathology.

B J Nankivell1, J Renthawa2, R N Sharma2, K Kable1, P J O'Connell1, J R Chapman1.   

Abstract

Reactivation of BK virus in renal allografts causes a destructive chronic infection. This single-center retrospective cohort study describes the evolution of BK virus allograft nephropathy (BKVAN) from 63 kidneys (from 61 patients) using sequential histopathology (454 biopsies, averaging 7.8 ± 2.6 per kidney) followed for 60.1 mo. Uninfected protocol biopsies formulated time-matched control Banff scores (n = 975). Interstitial inflammation occurred in 73% at diagnosis, correlating with viral histopathology (r = 0.413, p = 0.008) and amplifying early injury with accelerated interstitial fibrosis and tubular atrophy (IF/TA, p = 0.017) by 3 mo. Prodromal simian virus 40 large T antigen (SV40T)-negative inflammation with viremia preceded the histological diagnosis in 23.8%. Persistent subacute injury from viral cytopathic effect was associated with acute tubular necrosis and ongoing interstitial inflammation, culminating in IF/TA in 86.9%. Overall, cellular interstitial infiltration mitigated the intensity of subsequent tubular injury, SV40T, and tissue viral load, assessed by sequential paired histology (p < 0.001). Graft loss was predicted by high-level viremia (hazard ratio [HR] 4.996, 95% CI 2.19-11.396, p < 0.001), deceased donor (HR 3.201, 95% CI 1.149-8.915, p = 0.026), and late acute rejection (HR 3.124, 95% CI 1.037-9.413, p = 0.043). Transplant failure occurred in 38.1%, with uncontrolled infection (58.3%) and SV40T-negative chronic rejection (41.7%) causing losses. BKVAN is characterized by subacute virus-induced tubular injury, inflammation, and progressive nephron destruction. Effective antiviral therapy remains an unmet clinical need.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; complication: infectious; infection and infectious agents; infectious disease; kidney transplantation/nephrology; pathology/histopathology; viral: BK/JC/polyoma

Mesh:

Year:  2017        PMID: 28371308     DOI: 10.1111/ajt.14292

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  BK Virus RNA in Renal Allograft Biopsies.

Authors:  Francesca Costigliolo; Kara Lombardo; Lois J Arend; Avi Z Rosenberg; Andres Matoso; Naima Carter-Monroe; Serena M Bagnasco
Journal:  J Histochem Cytochem       Date:  2020-04-30       Impact factor: 2.479

2.  BK Virus Nephropathy.

Authors:  Deirdre Sawinski; Jennifer Trofe-Clark
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-21       Impact factor: 8.237

3.  [Early intervention of BK virus replication promotes stabilization of renal graft function].

Authors:  Wei-Ming Deng; Yan-Na Liu; Li-Xin Yu; Wen-Feng Deng; Shao-Jie Fu; Jian Xu; Chuan-Fu DU; Yi-Bin Wang; Ru-Min Liu; Gui-Rong Ye; Gang Huang; Yun Miao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

4.  The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.

Authors:  Volker Nickeleit; Harsharan K Singh; Parmjeet Randhawa; Cinthia B Drachenberg; Ramneesh Bhatnagar; Erika Bracamonte; Anthony Chang; W James Chon; Darshana Dadhania; Vicki G Davis; Helmut Hopfer; Michael J Mihatsch; John C Papadimitriou; Stefan Schaub; Michael B Stokes; Mohammad F Tungekar; Surya V Seshan
Journal:  J Am Soc Nephrol       Date:  2017-12-26       Impact factor: 10.121

Review 5.  Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss.

Authors:  Francesca Maremonti; Claudia Meyer; Andreas Linkermann
Journal:  J Am Soc Nephrol       Date:  2022-01-12       Impact factor: 10.121

6.  Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study.

Authors:  Carrie A Schinstock; Darshana M Dadhania; Matthew J Everly; Byron Smith; Manish Gandhi; Evan Farkash; Vijay K Sharma; Milagros Samaniego-Picota; Mark D Stegall
Journal:  Transpl Int       Date:  2019-02-08       Impact factor: 3.782

7.  Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials.

Authors:  Hannah Imlay; Paul Baum; Daniel C Brennan; Kimberly E Hanson; Michael R Hodges; Aimee C Hodowanec; Takashi E Komatsu; Per Ljungman; Veronica Miller; Yoichiro Natori; Volker Nickeleit; Jules O'Rear; Andreas Pikis; Parmjeet S Randhawa; Deirdre Sawinski; Harsharan K Singh; Gabriel Westman; Ajit P Limaye
Journal:  Clin Infect Dis       Date:  2022-09-30       Impact factor: 20.999

8.  Chaphamaparvovirus antigen and nucleic acids are not detected in kidney tissues from cats with chronic renal disease or immunocompromised cats.

Authors:  Adam O Michel; Taryn A Donovan; Ben Roediger; Quintin Lee; Christopher J Jolly; Sébastien Monette
Journal:  Vet Pathol       Date:  2021-10-03       Impact factor: 3.157

Review 9.  BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection.

Authors:  Chia-Lin Shen; Bo-Sheng Wu; Tse-Jen Lien; An-Hang Yang; Chih-Yu Yang
Journal:  Viruses       Date:  2021-03-16       Impact factor: 5.048

10.  Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States.

Authors:  Gaurav Gupta; Sarat Kuppachi; Roberto S Kalil; Christopher B Buck; Charles F Lynch; Eric A Engels
Journal:  Am J Transplant       Date:  2017-11-01       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.